{"title":"mRNA疫苗:为什么以及如何进行修饰","authors":"I. Feliciello, A. Procino","doi":"10.4081/jbr.2021.10072","DOIUrl":null,"url":null,"abstract":"Dear editor, \nThe COVID-19 pandemic has stimulated the production of different therapeutic approaches for the resolution of coronavirus infections. On one hand, nanobiomolecules have been proposed as bait material for viruses, 1 on the other hand unconventional messenger RNA vaccines have been produced like SARS-CoV-2 mRNA vaccines (BioNTech / Pfizer BNT162b2 and Moderna mRNA-1273). [...]","PeriodicalId":9116,"journal":{"name":"Bollettino della Societa italiana di biologia sperimentale","volume":"82 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"mRNA vaccines: Why and how they should be modified\",\"authors\":\"I. Feliciello, A. Procino\",\"doi\":\"10.4081/jbr.2021.10072\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dear editor, \\nThe COVID-19 pandemic has stimulated the production of different therapeutic approaches for the resolution of coronavirus infections. On one hand, nanobiomolecules have been proposed as bait material for viruses, 1 on the other hand unconventional messenger RNA vaccines have been produced like SARS-CoV-2 mRNA vaccines (BioNTech / Pfizer BNT162b2 and Moderna mRNA-1273). [...]\",\"PeriodicalId\":9116,\"journal\":{\"name\":\"Bollettino della Societa italiana di biologia sperimentale\",\"volume\":\"82 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-10-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bollettino della Societa italiana di biologia sperimentale\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4081/jbr.2021.10072\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bollettino della Societa italiana di biologia sperimentale","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4081/jbr.2021.10072","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
mRNA vaccines: Why and how they should be modified
Dear editor,
The COVID-19 pandemic has stimulated the production of different therapeutic approaches for the resolution of coronavirus infections. On one hand, nanobiomolecules have been proposed as bait material for viruses, 1 on the other hand unconventional messenger RNA vaccines have been produced like SARS-CoV-2 mRNA vaccines (BioNTech / Pfizer BNT162b2 and Moderna mRNA-1273). [...]